Meningococcal serogroup C vaccination in England and Wales: Coverage and initial impact of the campaign

CL Trotter, ME Ramsay, EB Kaczmarski

Research output: Contribution to journalArticle (Academic Journal)peer-review

Abstract

The UK was the first country to introduce meningococcal serogroup C conjugate vaccination. The vaccine was incorporated into the routine infant immunisation schedule and was offered to all under 18 year olds in a catch-up campaign. The vaccine has been well accepted in infants receiving routine vaccination, with coverage around 89%. Coverage in older children targeted in the catch-up campaign was above 85% up to the age of 14, and was lowest (43%) in 15-17 year olds not in education. The winter of 2000-01 was the first meningococcal season following the offer of the vaccination to all children and adolescents. The incidence of serogroup C disease in the targeted age groups fell by 80%, and the number of deaths in laboratory confirmed cases in 0-19 year olds decreased from 78 to 8 between 1998-99 and 2000-01. The incidence of serogroup B disease in all age groups was slightly higher in 2000-01 than previous years, and there was an increase in the incidence of serogroup C disease in those aged over 20 during the study period, leading to the extension of the vaccination campaign to 20-24 year olds.
Translated title of the contributionMeningococcal serogroup C vaccination in England and Wales: Coverage and initial impact of the campaign
Original languageEnglish
Pages (from-to)220 - 225
JournalCommunicable Disease and Public Health
Volume5
Publication statusPublished - 2002

Bibliographical note

Publisher: Public Health Laboratory Service

Fingerprint Dive into the research topics of 'Meningococcal serogroup C vaccination in England and Wales: Coverage and initial impact of the campaign'. Together they form a unique fingerprint.

Cite this